Andrea Ambrosini-Spaltro

Dr. Andrea Ambrosini-Spaltro

Pathology Unit, Ospedale G.B. Morgagni - L.Pierantoni, Forlì, Emilia-Romagna, Italy
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2009 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
SJShabnam Jaffer
Shabnam Jaffer
Andrea Ambrosini-SpaltroAndrea Ambrosini-Spaltro
Andrea Ambrosini-Spaltro
AMAntonio M. Mancini
Antonio M. Mancini
VEVincenzo Eusebi
Vincenzo Eusebi
JRJuan Rosai
Juan Rosai
Neurothekeoma (NTK) and plexiform fibrohistiocytic tumor (PFHT) are dermal neoplasms that share many clinical and histologic features and whose histogenesis is equally disputed. We analyzed the morphologic and immunohistochemical features of 43 NTK and 18 PFHT to evaluate a possible relationship between these tumors. On the basis of the amount of myxoid stroma, we divided NTK into myxoid neurothekeoma (MyNTK) (8 cases), mixed neurothekeoma (MiNTK) (15 cases), and cellular neurothekeoma (CNTK) (20 cases). MyNTK and MiNTK were well circumscribed lesions composed of spindle cells. CNTK had an infiltrative quality and consisted of predominantly epithelioid cells, with over 50% of the cases containing multinucleated giant cells. PFHT were predominantly composed of epithelioid cells in 11 cases, spindle cells in 1, and an even admixture of spindle and epithelioid cells in 6 cases. Their morphologic features (particularly those of the more epithelioid examples) were superimposable to those of CNTK. Immunohistochemically, there was positivity for S100 protein in 8 of 8 MyNTK, 4 of 15 MiNTK, 1 of 19 CNTK, and 0 of 18 PFHT. There was positivity for CD68 in 0 of 8 MyNTK, 6 of 15 MiNTK, 9 of 17 CNTK, and 6 of 11 PFHT. These results suggest the existence of a continuum between MyNTK and MiNTK. Furthermore, the marked morphologic and phenotypic similarities between CNTK and PFHT suggest a common histogenesis for these 2 tumors, different from that of MyNTK and MiNTK.

1 February 2009 in Neurosurgery
Verified
Journal Article
Closed access
RCRiccardo Ciarpaglini
Riccardo Ciarpaglini
EPErnesto Pasquini
Ernesto Pasquini
DMDiego Mazzatenta
Diego Mazzatenta
Andrea Ambrosini-SpaltroAndrea Ambrosini-Spaltro
Andrea Ambrosini-Spaltro
VSVittorio Sciarretta
Vittorio Sciarretta
GFGiorgio Frank
Giorgio Frank
Purely intradural clival chordomas are rare neoplasms, and only a few cases have been reported. The reported cases present features similar to ecchordosis physaliphora, which is a notochordal remnant. We describe these 2 entities and their differential diagnoses, clinical courses, and management. This is the first reported case to be treated using a neuroendoscopic technique. A 60-year-old man presenting with memory loss underwent magnetic resonance imaging, which revealed an intradural retroclival mass without bone involvement. The patient underwent an endoscopic transsphenoidal-transclival procedure with subtotal removal of the tumor. Histological findings confirmed the diagnosis of a chordoma. Even if some parameters exist for a differential diagnosis, ecchordosis physaliphora and intradural chordoma may represent different aspects of the spectrum of the same pathology. Intradural clival chordomas have a better prognosis with respect to classic chordomas. Therefore, in subtotal removal such as that performed in our case, postoperative radiation therapy should be performed only if a regrowth of the remnant is seen during neuroradiological follow-up.

12 March 2013 in Cancer Cytopathology
Verified
Journal Article
Open access
PDF file
ECEvi Comploj
Evi Comploj
CMChristine Mian
Christine Mian
Andrea Ambrosini-SpaltroAndrea Ambrosini-Spaltro
Andrea Ambrosini-Spaltro
CDChristopher Dechet
Christopher Dechet
SPSalvatore Palermo
Salvatore Palermo
APArmin Pycha
Armin Pycha
BACKGROUND: The aim of the current study was to report the results of 7422 uCyt+/ImmunoCyt and cytology analyses that were performed over the course of 9 years at the study institution for the evaluation and follow‐up of patients with urothelial carcinoma.METHODS: Between January 2002 and March 2011, 2217 patients with a mean age of 69.5 years (range, 15 years‐99 years) were enrolled in the current study. All patients seen for the follow‐up of bladder and/or upper tract urothelial cancer as well as those with a history that was suspicious for bladder cancer were recruited. In all patients, a voided urinary cytology and uCyt+/ImmunoCyt test was performed. Patients underwent routine cystoscopy as well as cystoscopy when cytology and/or the uCyt+/ImmunoCyt test yielded positive results. Lesions that were detected cystoscopically were biopsied and removed transurethrally. A total of 7422 uCyt+/ImmunoCyt and cytology analyses were performed.RESULTS: Of the 7422 uCyt+/ImmunoCyt tests and cytologies that were performed, 7075 (95.3%) were considered adequate. A total of 578 patients (with 1156 analyses) underwent biopsy and 728 (63%) samples had a histologically proven urothelial carcinoma. Overall sensitivity was 34.5% for cytology, 68.1% for uCyt+/ImmunoCyt, and 72.8% for the 2 tests combined. Overall specificity was 97.9% for cytology, 72.3% for uCyt+/ImmunoCyt, and 71.9% for the 2 tests combined. Cytology and the uCyt+/ImmunoCyt test together had an overall sensitivity of 72.8%, with 59% for grade 1, 77% for grade 2, and 90% for grade 3 tumors (according to the 1973 World Health Organization grading classification system).CONCLUSIONS: On the basis of their 9‐year experience, the authors confirm the value of uCyt+/ImmunoCyt and cytology analyses in the follow‐up of patients with non–muscle‐invasive urothelial cancer. This could potentially reduce the number and cost of routine cystoscopic examinations in patients who are followed for bladder carcinoma. Cancer (Cancer Cytopathol) 2013;121:392–397. © 2013 American Cancer Society.

5 October 2010 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
Andrea Ambrosini-SpaltroAndrea Ambrosini-Spaltro
Andrea Ambrosini-Spaltro
LMLuca Morandi
Luca Morandi
DSDominic V. Spagnolo
Dominic V. Spagnolo
ACAlberto Cavazza
Alberto Cavazza
MBMassimo Brisigotti
Massimo Brisigotti
VEVincenzo Eusebi
Vincenzo Eusebi


29 October 2013 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
ECEvi Comploj
Evi Comploj
CDChristopher B. Dechet
Christopher B. Dechet
MMMichael Mian
Michael Mian
ETEmanuela Trenti
Emanuela Trenti
SPSalvatore Palermo
Salvatore Palermo
APArmin Pycha
Armin Pycha